NUDT16 Human

Nudix Type Motif 16 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Enzymatic Activities and Substrate Specificity

NUDT16 exhibits bifunctional activity, acting as both an RNA decapping enzyme and a nucleotide sanitizer:

Substrate Profile

Substrate TypeCatalytic Efficiency (kₐₜ/Kₘ)Key Role
(d)IDP/(d)ITPHighDetoxifies inosine nucleotides
NAD/FAD-capped RNAsModerateRemoves metabolite RNA caps
ADP-riboseLowProcesses protein conjugates
m⁷G-capped RNAsModerateInitiates mRNA decay

Data compiled from

  • Mechanism: Hydrolysis occurs at diphosphate linkages, releasing monophosphates (e.g., IMP from IDP) .

  • Discrimination factors:

    • Position 6 substituents: Carbonyl groups (e.g., in inosine) enhance binding via Phe57 interactions .

    • Position 2 substituents: Bulky groups disrupt Ser166-mediated H-bond networks, reducing affinity .

Regulatory Mechanisms

NUDT16 activity is tightly controlled by:

  • Product inhibition: IMP competitively inhibits NUDT16 with an IC₅₀ of ~10 μM, prioritizing IDP hydrolysis over non-toxic substrates like ADP .

  • Cellular IMP levels: Micromolar IMP concentrations in tissues (e.g., liver, muscle) modulate enzyme activity, preventing nucleotide pool imbalance .

  • Post-translational modifications: Structural flexibility in loop regions (e.g., β-strand G to α-helix 2a) influences substrate access .

Cancer

  • T-cell acute lymphoblastic leukemia (T-ALL): Epigenetic silencing of NUDT16 promotes cell proliferation. Restoring NUDT16 expression reduces tumor growth in vitro and in vivo (Table 1) .

  • DNA damage mitigation: NUDT16 prevents single-strand DNA breaks by clearing dITP, whose incorporation into DNA triggers repair-induced genomic instability .

Neurodegenerative Disorders

  • Huntington’s disease: Expanded CAG RNAs downregulate NUDT16 via sCAG-CUG heteroduplex formation, leading to DNA damage and neuronal apoptosis. Small-molecule inhibitors (e.g., DB213) blocking this interaction rescue NUDT16 expression and reduce pathology .

Table 1: Disease Associations of NUDT16

DiseaseMechanismOutcome
T-ALLPromoter hypermethylation silences NUDT16Uncontrolled cell proliferation
Huntington’s diseasesCAG RNAs suppress NUDT16 via RISC-mediated silencingDNA damage, neuronal apoptosis
In vitro toxicitydITP accumulation due to NUDT16 deficiencyS-phase cell cycle arrest

Data from

Functional Redundancy and Evolution

  • Overlap with Dcp2: NUDT16 complements Dcp2 in mRNA decay pathways, particularly for AU-rich and miRNA-targeted transcripts .

  • Conservation: Orthologs in Xenopus laevis (X29) and mammals share structural motifs (e.g., GFP loop), underscoring evolutionary importance in nucleotide sanitation .

Therapeutic Targeting

  • Small-molecule modulators: Bisamidinium compounds (e.g., DB213) disrupt pathogenic RNA duplexes, restoring NUDT16 levels in Huntington’s models .

  • Enzyme engineering: NUDT16 mutants (e.g., F36A, Δ17) show enhanced activity toward poly-ADP-ribosylated proteins, suggesting utility in PARP inhibitor therapies .

Product Specs

Introduction
NUDT16, a nuclear nucleoside diphosphatase protein, is localized in specific spots within the nucleolus and nucleoplasm. This protein functions as an RNA-decapping enzyme, exhibiting specific binding to U8 snoRNA. NUDT16 removes m7G and m227G caps from RNA molecules, enabling their degradation by 5' to 3' exonucleases in living cells.
Description
Produced in E. coli, NUDT16 is a single, non-glycosylated polypeptide chain comprising 215 amino acids (1-195a.a.) with a molecular weight of 23.4kDa. This protein is expressed with a 20 amino acid His-tag at the N-terminus and purified using proprietary chromatographic methods.
Physical Appearance
Clear, sterile solution after filtration.
Formulation
The NUDT16 protein solution is provided at a concentration of 1mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 1mM DTT, 100mM NaCl, and 10% glycerol.
Purity
Purity exceeds 95% as assessed by SDS-PAGE analysis.
Stability
For short-term storage (2-4 weeks), the product should be kept at 4°C. For long-term storage, it is recommended to freeze the product at -20°C. Repeated freezing and thawing cycles should be avoided.
Synonyms
Nudix (nucleoside diphosphate linked moiety X)-Type Motif 16, FLJ31265, FLJ34034, FLJ36248, U8 snoRNA-binding protein H29K, U8 snoRNA-decapping enzyme.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MAGARRLELG EALALGSGWR HACHALLYAP DPGMLFGRIP LRYAILMQMR FDGRLGFPGG FVDTQDRSLE DGLNRELREE LGEAAAAFRV ERTDYRSSHV GSGPRVVAHF YAKRLTLEEL LAVEAGATRA KDHGLEVLGL VRVPLYTLRD GVGGLPTFLE NSFIGSAREQ LLEALQDLGL LQSGSISGLK IPAHH

Q&A

What is NUDT16 and what is its primary function in human cells?

NUDT16 is a nuclear RNA decapping protein belonging to the NUDIX (Nucleoside Diphosphate linked to X) family of proteins, which eliminate potentially toxic nucleotide derivatives from cells. In humans, NUDT16 functions primarily in nuclear RNA degradation pathways by hydrolyzing the m7G cap from the 5′-end of RNAs . This protein plays an essential role in RNA turnover and quality control mechanisms.

Methodologically, researchers should approach NUDT16 functional studies through:

  • In vitro decapping assays using radiolabeled capped RNA substrates

  • Subcellular fractionation to confirm nuclear localization

  • RNA-protein binding assays to characterize substrate specificity

  • Gene knockdown/knockout studies to observe effects on cellular RNA processing

How is NUDT16 evolutionarily conserved across species?

NUDT16 demonstrates remarkable evolutionary conservation, with putative orthologs identified in 57 different organisms ranging from humans to Cnidaria (anemones/corals) . This conservation suggests an ancient origin and fundamental biological importance. Functional studies have demonstrated that insect orthologs can bind RNA and hydrolyze the m7G cap, indicating functional conservation across metazoans .

Notably, NUDT16 orthologs contain three conserved structural/functional regions:

  • The NUDIX domain responsible for catalytic activity

  • Two additional conserved regions that maintain structural integrity

The phylogenetic trees generated from NUDT16 ortholog alignments generally follow accepted evolutionary relationships, showing a clear division between vertebrates and invertebrates, with mammals grouped with marsupials and monotremes .

What is the relationship between NUDT16 and Syndesmos in humans?

Syndesmos is a paralogous protein to NUDT16 that resulted from gene duplication during tetrapod evolution, occurring near the amniote divergence . Unlike NUDT16, Syndesmos:

  • Is associated with the cytoplasmic membrane rather than the nucleus

  • Lacks decapping activity but retains RNA-binding capability

  • Interacts with Syndecan-4 and the Paxillin family of proteins

  • When overexpressed, enhances cell spreading and focal contact formation

The table below shows the comparative analysis of NUDT16 and Syndesmos across various organisms:

OrganismNUDT16:Syndesmos Identity (%)NUDT16:Syndesmos Similarity (%)Human NUDT16 vs. Organism NUDT16 (%)Human Syndesmos vs. Organism Syndesmos (%)NUDT16 ChromosomeSyndesmos Chromosome
Human6175100100316
Chimpanzee61709970316
Mouse58727995916
Rat60736897810
Bovine6273829725
Opossum54696592X6
Average56677180--

This data demonstrates the sequence divergence between these paralogs while highlighting their evolutionary relationship .

What experimental techniques are most effective for studying NUDT16 expression patterns?

For comprehensive NUDT16 expression analysis, researchers should employ multiple complementary approaches:

  • RT-qPCR: For quantitative measurement of transcript levels across tissues and cell types

  • Western blotting: To determine protein expression levels using validated antibodies

  • Immunofluorescence microscopy: To visualize subcellular localization and potential co-localization with other nuclear components

  • RNA-sequencing: To identify splice variants and expression patterns under different cellular conditions

  • Chromatin immunoprecipitation: To investigate transcriptional regulation of NUDT16

When designing expression studies, careful consideration should be given to:

  • Cell/tissue type selection based on known expression patterns

  • Appropriate housekeeping genes for normalization

  • Antibody validation to ensure specificity between NUDT16 and Syndesmos

  • Experimental controls to account for potential cross-reactivity

What experimental approaches are most effective for studying NUDT16 decapping activity in vitro?

For rigorous characterization of NUDT16 decapping activity, researchers should implement:

  • Protein purification: Express recombinant NUDT16 with appropriate tags (His, GST) in bacterial systems, followed by affinity chromatography and size exclusion purification

  • Substrate preparation: Generate capped RNA substrates with 32P-labeled caps or fluorescently labeled RNAs

  • Decapping assays: Incubate purified NUDT16 with labeled substrates under varying conditions (pH, temperature, divalent cations)

  • Product analysis: Use thin-layer chromatography or HPLC to separate and quantify reaction products

Critical methodological considerations include:

  • Ensuring protein preparations are free from contaminating nucleases

  • Testing both monomeric and dimeric forms of NUDT16, as dimerization affects activity

  • Including appropriate controls such as catalytically inactive mutants

  • Varying substrate length and structure to determine specificity

The functional conservation of NUDT16 across species makes comparative biochemical studies valuable. For example, insect orthologs have been demonstrated to retain RNA-binding and decapping activities similar to vertebrate proteins .

How can researchers effectively differentiate between NUDT16 and Syndesmos in experimental systems?

Distinguishing between these paralogous proteins requires stringent experimental approaches:

  • Sequence-specific antibodies: Generate antibodies targeting non-conserved regions to avoid cross-reactivity

  • Subcellular fractionation: NUDT16 is predominantly nuclear while Syndesmos is cytoplasmic

  • Functional assays: Only NUDT16 exhibits decapping activity, while both proteins bind RNA

  • Dimerization analysis: NUDT16 forms homodimers (though human NUDT16 dimerizes less readily than Xenopus orthologs), while Syndesmos does not form detectable homodimers under standard chemical cross-linking conditions

For genetic studies, researchers should:

  • Design primers/probes that target unique regions in each gene

  • Validate knockdown/knockout specificity through multiple detection methods

  • Consider potential compensatory mechanisms when one paralog is disrupted

What experimental design considerations are critical when investigating NUDT16's role in RNA metabolism pathways?

When designing experiments to study NUDT16's role in RNA metabolism:

  • Subject selection and grouping:

    • Define sample characteristics to exclude side effects that could alter experimental outcomes

    • Ensure demographic consistency across respondent pools

    • Consider individual characteristics that might affect experimental outcomes

    • Randomly assign subjects to experimental groups to avoid bias

  • RNA substrate selection:

    • Include various RNA types (mRNA, snRNA, snoRNA) as NUDT16 may exhibit substrate preferences

    • Consider RNA structural elements that might influence decapping efficiency

    • Compare capped and uncapped RNAs as controls

  • Temporal considerations:

    • Determine appropriate sampling frequency to capture dynamic changes in RNA metabolism

    • Design time-course experiments to monitor decapping activity progression

    • Consider cell cycle effects on NUDT16 activity and localization

  • Data analysis approaches:

    • Implement robust statistical methods appropriate for the experimental design

    • Consider potential confounding variables

    • Validate findings through multiple experimental approaches

How can CRISPR/Cas9 technology be optimized for studying NUDT16 function in human cells?

For effective CRISPR/Cas9-based NUDT16 studies:

  • Guide RNA design:

    • Target conserved functional domains for complete knockout

    • Design multiple gRNAs targeting different exons to increase editing efficiency

    • Verify specificity to avoid off-target effects, particularly with Syndesmos

  • Validation strategies:

    • Confirm editing at genomic level through sequencing

    • Verify protein depletion via Western blotting

    • Assess functional consequences through decapping assays

  • Experimental controls:

    • Include non-targeting gRNA controls

    • Generate rescue cell lines expressing CRISPR-resistant NUDT16 variants

    • Create parallel Syndesmos knockouts to distinguish paralog-specific functions

  • Phenotypic analysis:

    • Examine global RNA stability using RNA-seq or metabolic labeling

    • Analyze nuclear RNA accumulation patterns

    • Investigate potential compensatory mechanisms

What are the methodological challenges in resolving discrepancies in NUDT16 functional data across experimental systems?

Researchers face several challenges when reconciling disparate NUDT16 functional data:

  • Protein variants and isoforms:

    • Different splice variants may predominate across cell types

    • Post-translational modifications can alter activity

    • Methodological approach: Characterize all NUDT16 isoforms present in your experimental system

  • Experimental conditions:

    • Buffer compositions significantly affect enzymatic activity

    • Divalent cation concentrations are critical for NUDIX hydrolase function

    • Methodological approach: Standardize reaction conditions across experiments and clearly report all buffer components

  • Protein purification strategies:

    • Tag position can affect protein folding and activity

    • Bacterial vs. eukaryotic expression systems yield differently modified proteins

    • Methodological approach: Compare multiple purification strategies and validate protein functionality

  • Dimerization states:

    • NUDT16 forms homodimers with varying efficiency across species

    • Dimerization affects substrate binding and catalytic activity

    • Methodological approach: Analyze both monomeric and dimeric forms separately

  • Cross-species comparisons:

    • Despite conservation, species-specific differences exist in NUDT16 function

    • Methodological approach: Include appropriate controls when extrapolating between model organisms

Product Science Overview

Structure and Function

NUDT16 is a single, non-glycosylated polypeptide chain consisting of 215 amino acids . It is produced in Escherichia coli (E. coli) and purified through proprietary chromatographic techniques . The protein plays a crucial role in the metabolism of nucleotides, particularly in the decapping of U8 small nucleolar RNA (snoRNA), which is essential for the proper processing and maturation of ribosomal RNA (rRNA).

Biological Significance

NUDT16 is involved in several critical cellular processes, including:

  • RNA Processing: By decapping U8 snoRNA, NUDT16 ensures the correct processing of rRNA, which is vital for ribosome biogenesis and protein synthesis.
  • Nucleotide Metabolism: It hydrolyzes various nucleoside diphosphates, thereby regulating the levels of these molecules within the cell.
  • Stress Response: NUDT16 activity is linked to cellular responses to oxidative stress, as it helps in the removal of potentially harmful oxidized nucleotides.
Research and Applications

The recombinant form of NUDT16 is widely used in research to study its enzymatic activity, substrate specificity, and role in cellular metabolism. Understanding the function of NUDT16 can provide insights into the mechanisms of RNA processing and the cellular response to oxidative stress. Additionally, it has potential applications in the development of therapeutic strategies for diseases related to nucleotide metabolism and RNA processing.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.